BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 16491119)

  • 1. The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10.
    Archangelo LF; Gläsner J; Krause A; Bohlander SK
    Oncogene; 2006 Jul; 25(29):4099-109. PubMed ID: 16491119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia driven by the CALM-AF10 fusion gene is dependent on BMI1.
    Barbosa K; Deshpande A; Chen BR; Ghosh A; Sun Y; Dutta S; Weetall M; Dixon J; Armstrong SA; Bohlander SK; Deshpande AJ
    Exp Hematol; 2019 Jun; 74():42-51.e3. PubMed ID: 31022428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of T/myeloid mixed-phenotype acute leukemia with the translocation (10;11)(p13;q14)
    Krzisch D; Zduniak A; Veresezan EL; Daliphard S; Contentin N; Penther D; Etancelin P; Jardin F; Camus V
    Clin Case Rep; 2021 Mar; 9(3):1507-1513. PubMed ID: 33768878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unusual presentation of a pediatric patient with mixed phenotypic acute leukemia with
    Smith E; Krishnan C
    Pediatr Hematol Oncol; 2023; 40(8):778-785. PubMed ID: 37171905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keep calm and carry on: AIG2A/B prevent over-activation of TDSM-mediated defense response.
    Chan C
    Plant Cell; 2022 Oct; 34(11):4126-4127. PubMed ID: 36048118
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute myeloid leukemia with rare recurring translocations-an overview of the entities included in the international consensus classification.
    Rørvik SD; Torkildsen S; Bruserud Ø; Tvedt THA
    Ann Hematol; 2024 Apr; 103(4):1103-1119. PubMed ID: 38443661
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Yao H; Lyu F; Ma J; Sun F; Tang G; Wu J; Zhou Z
    Front Oncol; 2023; 13():1035321. PubMed ID: 36776322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postnatal expression of cell cycle promoter Fam64a causes heart dysfunction by inhibiting cardiomyocyte differentiation through repression of Klf15.
    Hashimoto K; Kodama A; Ohira M; Kimoto M; Nakagawa R; Usui Y; Ujihara Y; Hanashima A; Mohri S
    iScience; 2022 May; 25(5):104337. PubMed ID: 35602953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FAM64A promotes HNSCC tumorigenesis by mediating transcriptional autoregulation of FOXM1.
    Zhao X; Chen H; Qiu Y; Cui L
    Int J Oral Sci; 2022 May; 14(1):25. PubMed ID: 35538067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocytic protein intersectin1-S shuttles into nucleus to suppress the DNA replication in breast cancer.
    Zhang H; Guo Z; Liu X; Zhao Y; Chen Y; Zhang M; Fu L; Gu F; Ma Y
    Cell Death Dis; 2021 Oct; 12(10):922. PubMed ID: 34625530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role.
    Zhu H; Hu X; Ye Y; Jian Z; Zhong Y; Gu L; Xiong X
    Front Genet; 2021; 12():687778. PubMed ID: 34594356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma.
    Jiang F; Liang M; Huang X; Shi W; Wang Y
    PeerJ; 2021; 9():e11697. PubMed ID: 34268011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAM64A is an androgen receptor-regulated feedback tumor promoter in prostate cancer.
    Zhou Y; Ou L; Xu J; Yuan H; Luo J; Shi B; Li X; Yang S; Wang Y
    Cell Death Dis; 2021 Jul; 12(7):668. PubMed ID: 34215720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIMREG, a Marker of Proliferation, Facilitates Aggressive Development of Cholangiocarcinoma Cells Partly Through Regulating Cell Cycle-Related Markers.
    Jiang ZM; Li HB; Chen SG
    Technol Cancer Res Treat; 2020; 19():1533033820979681. PubMed ID: 33356974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes.
    Shinden Y; Hirashima T; Nohata N; Toda H; Okada R; Asai S; Tanaka T; Hozaka Y; Ohtsuka T; Kijima Y; Seki N
    J Hum Genet; 2021 May; 66(5):519-534. PubMed ID: 33177704
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Mizuno K; Tanigawa K; Nohata N; Misono S; Okada R; Asai S; Moriya S; Suetsugu T; Inoue H; Seki N
    Cells; 2020 Sep; 9(9):. PubMed ID: 32932948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of dietary folate and vitamin B-12 intake with genome-wide DNA methylation in blood: a large-scale epigenome-wide association analysis in 5841 individuals.
    Mandaviya PR; Joehanes R; Brody J; Castillo-Fernandez JE; Dekkers KF; Do AN; Graff M; Hänninen IK; Tanaka T; de Jonge EAL; Kiefte-de Jong JC; Absher DM; Aslibekyan S; de Rijke YB; Fornage M; Hernandez DG; Hurme MA; Ikram MA; Jacques PF; Justice AE; Kiel DP; Lemaitre RN; Mendelson MM; Mikkilä V; Moore AZ; Pallister T; Raitakari OT; Schalkwijk CG; Sha J; Slagboom EPE; Smith CE; Stehouwer CDA; Tsai PC; Uitterlinden AG; van der Kallen CJH; van Heemst D; Arnett DK; Bandinelli S; Bell JT; Heijmans BT; Lehtimäki T; Levy D; North KE; Sotoodehnia N; van Greevenbroek MMJ; van Meurs JBJ; Heil SG
    Am J Clin Nutr; 2019 Aug; 110(2):437-450. PubMed ID: 31165884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAM64A positively regulates STAT3 activity to promote Th17 differentiation and colitis-associated carcinogenesis.
    Xu ZS; Zhang HX; Li WW; Ran Y; Liu TT; Xiong MG; Li QL; Wang SY; Wu M; Shu HB; Xia H; Wang YY
    Proc Natl Acad Sci U S A; 2019 May; 116(21):10447-10452. PubMed ID: 31061131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of PIMREG promotes breast cancer aggressiveness via constitutive activation of NF-κB signaling.
    Jiang L; Ren L; Zhang X; Chen H; Chen X; Lin C; Wang L; Hou N; Pan J; Zhou Z; Huang H; Huang D; Yang J; Liang Y; Li J
    EBioMedicine; 2019 May; 43():188-200. PubMed ID: 30979686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer.
    Jiao Y; Fu Z; Li Y; Zhang W; Liu Y
    PLoS One; 2019; 14(1):e0211291. PubMed ID: 30695070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.